» Articles » PMID: 12846581

Inhibition of Tau Polymerization by Its Carboxy-terminal Caspase Cleavage Fragment

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2003 Jul 9
PMID 12846581
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormal aggregation of the microtubule-associated protein, tau, occurs in many neurodegenerative diseases, making it important to understand the mechanisms of tau polymerization. Previous work has indicated that the C-terminal region of tau inhibits polymerization in vitro, and a growing body of evidence implicates caspase cleavage of tau at Asp 421 in the C-terminus as an important inducer of tau polymerization in Alzheimer's disease. In the present study, we provide evidence that the C-terminal peptide fragment produced by caspase cleavage inhibits tau polymerization, suggesting that caspase cleavage of tau enhances its polymerization by removing the inhibitory control element. Moreover, we provide evidence that the peptide assumes an alpha-helical configuration and inhibits tau assembly by interacting with residues 321-375 in the microtubule binding repeat region. These findings indicate that formation of the fibrillar pathologies during the course of Alzheimer's disease may be driven or sustained by apoptotic events leading to caspase activation.

Citing Articles

Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases.

Ye Q, Li X, Gao W, Gao J, Zheng L, Zhang M Front Neurosci. 2024; 18:1481983.

PMID: 39628659 PMC: 11613983. DOI: 10.3389/fnins.2024.1481983.


JNK3 Overexpression in the Entorhinal Cortex Impacts on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding.

Ardanaz C, Ezkurdia A, Bejarano A, Echarte B, Smerdou C, Martisova E ACS Chem Neurosci. 2023; 14(11):2074-2088.

PMID: 37236204 PMC: 10251484. DOI: 10.1021/acschemneuro.3c00092.


JNK Activation in Alzheimer's Disease Is Driven by Amyloid β and Is Associated with Tau Pathology.

Solas M, Vela S, Smerdou C, Martisova E, Martinez-Valbuena I, Luquin M ACS Chem Neurosci. 2023; .

PMID: 36976903 PMC: 10119940. DOI: 10.1021/acschemneuro.3c00093.


The Interplay between GSK3β and Tau Ser262 Phosphorylation during the Progression of Tau Pathology.

Song L, Oseid D, Wells E, Robinson A Int J Mol Sci. 2022; 23(19).

PMID: 36232909 PMC: 9569960. DOI: 10.3390/ijms231911610.


Retromer deficiency in Tauopathy models enhances the truncation and toxicity of Tau.

Asadzadeh J, Ruchti E, Jiao W, Limoni G, MacLachlan C, Small S Nat Commun. 2022; 13(1):5049.

PMID: 36030267 PMC: 9420134. DOI: 10.1038/s41467-022-32683-5.